Neeta Tandon

993 total citations
34 papers, 649 citations indexed

About

Neeta Tandon is a scholar working on Epidemiology, Hepatology and Psychiatry and Mental health. According to data from OpenAlex, Neeta Tandon has authored 34 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 9 papers in Psychiatry and Mental health. Recurrent topics in Neeta Tandon's work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Schizophrenia research and treatment (9 papers). Neeta Tandon is often cited by papers focused on Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (9 papers) and Schizophrenia research and treatment (9 papers). Neeta Tandon collaborates with scholars based in United States, Canada and Belgium. Neeta Tandon's co-authors include Patrick Lefèbvre, Dominic Pilon, Rhiannon Kamstra, Jennifer R. Frytak, Carolyn Harley, Marie‐Hélène Lafeuille, Bruno Émond, Kruti Joshi, S. Bolge and Amir Goren and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and The Journal of Clinical Psychiatry.

In The Last Decade

Neeta Tandon

33 papers receiving 631 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Neeta Tandon United States	14	252	150	117	87	84	34	649
K. Lehtinen Finland	18	244 1.0×	637 4.2×	107 0.9×	45 0.5×	48 0.6×	37	1.2k
Susan Gabriel United States	5	196 0.8×	90 0.6×	25 0.2×	12 0.1×	32 0.4×	10	397
Richard L. Siegel United States	21	1.0k 4.1×	147 1.0×	109 0.9×	73 0.8×	44 0.5×	33	1.6k
Araceli Caballero-Hidalgo Spain	9	108 0.4×	38 0.3×	16 0.1×	92 1.1×	18 0.2×	17	431
Bernadette Khoshaba United Kingdom	14	180 0.7×	288 1.9×	33 0.3×	41 0.5×	10 0.1×	20	707
Samer Hammoudeh Qatar	11	72 0.3×	100 0.7×	17 0.1×	37 0.4×	30 0.4×	50	410
Ben Palmer United Kingdom	16	87 0.3×	133 0.9×	64 0.5×	54 0.6×	104 1.2×	24	991
Natalie C. Edwards United States	11	162 0.6×	36 0.2×	21 0.2×	15 0.2×	19 0.2×	21	415
Jesús Tornero Molina Spain	12	55 0.2×	173 1.2×	131 1.1×	22 0.3×	14 0.2×	34	438
Kelly P. McCarrier United States	13	76 0.3×	21 0.1×	58 0.5×	83 1.0×	18 0.2×	36	493

Countries citing papers authored by Neeta Tandon

Since Specialization

Citations

This map shows the geographic impact of Neeta Tandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeta Tandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeta Tandon more than expected).

Fields of papers citing papers by Neeta Tandon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeta Tandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeta Tandon. The network helps show where Neeta Tandon may publish in the future.

Co-authorship network of co-authors of Neeta Tandon

This figure shows the co-authorship network connecting the top 25 collaborators of Neeta Tandon. A scholar is included among the top collaborators of Neeta Tandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neeta Tandon. Neeta Tandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Charmi, Bruno Émond, Marie‐Hélène Lafeuille, et al.. (2019). Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate. Drugs - Real World Outcomes. 7(1). 19–29. 22 indexed citations

Mejías, Asunción, et al.. (2019). Risk of childhood wheeze and asthma after respiratory syncytial virus infection in full‐term infants. Pediatric Allergy and Immunology. 31(1). 47–56. 31 indexed citations

Benson, Carmela, Bruno Émond, Patrick Lefèbvre, et al.. (2019). Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus. Journal of Managed Care & Specialty Pharmacy. 26(2). 117–128. 3 indexed citations

Mejías, Asunción, et al.. (2018). 2352. Increased on Childhood Recurrent Wheezing and Asthma After Respiratory Syncytial Viral (RSV) Infection in Full-Term Infants. Open Forum Infectious Diseases. 5(suppl_1). S699–S700.

Lafeuille, Marie‐Hélène, Xiaolong Jiao, Bruno Émond, et al.. (2018). Risk Factors, Health Care Resource Utilization, and Costs Associated with Nonadherence to Antiretrovirals in Medicaid-Insured Patients with HIV. Journal of Managed Care & Specialty Pharmacy. 24(10). 1040–1051. 13 indexed citations

Émond, Bruno, Kruti Joshi, Antoine C. El Khoury, et al.. (2018). Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate. PharmacoEconomics - Open. 3(2). 177–188. 13 indexed citations

Amos, Tony B., Neeta Tandon, Patrick Lefèbvre, et al.. (2018). Direct and Indirect Cost Burden and Change of Employment Status in Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 79(2). 24–32. 105 indexed citations

Émond, Bruno, Antoine C. El Khoury, Charmi Patel, et al.. (2018). Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans. Current Medical Research and Opinion. 35(3). 407–416. 15 indexed citations

Lafeuille, Marie‐Hélène, Neeta Tandon, Rhiannon Kamstra, et al.. (2018). Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics. Drugs - Real World Outcomes. 5(1). 81–90. 10 indexed citations

10.

Pilon, Dominic, Kruti Joshi, Neeta Tandon, et al.. (2017). Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic. Patient Preference and Adherence. Volume 11. 619–629. 41 indexed citations

11.

Bichoupan, Kian, Neeta Tandon, Valérie Martel‐Laferrière, et al.. (2017). Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection. World Journal of Hepatology. 9(11). 551–551. 1 indexed citations

12.

Pilon, Dominic, Neeta Tandon, Marie‐Hélène Lafeuille, et al.. (2017). Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics. Clinical Therapeutics. 39(10). 1972–1985.e2. 78 indexed citations

13.

LaMori, Joyce, Neeta Tandon, François Laliberté, et al.. (2015). Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C. Journal of Medical Economics. 19(4). 364–373. 9 indexed citations

14.

LaMori, Joyce, Neeta Tandon, François Laliberté, et al.. (2015). Predictors of High Healthcare Resource Utilization and Liver Disease Progression among Patients with Chronic Hepatitis C. Value in Health. 18(3). A225–A225. 1 indexed citations

15.

Bolge, S., Amir Goren, & Neeta Tandon. (2015). Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspective. Patient Preference and Adherence. 9. 121–121. 63 indexed citations

16.

Tandon, Neeta, Luis A. Balart, François Laliberté, et al.. (2014). Impact of completing chronic hepatitis C (CHC) treatment on post-therapy healthcare cost. Journal of Medical Economics. 17(12). 862–871. 13 indexed citations

17.

Tandon, Neeta, K. Rajender Reddy, Patrick Lefèbvre, et al.. (2013). Direct And Indirect Cost Burden Of Chronic Hepatitis C Infection In Privately-Insured Patients, Stratified By Liver Disease Severity. Value in Health. 16(3). A6–A6. 3 indexed citations

18.

Kavanaugh, Arthur, Iain B. McInnes, Gerald G. Krueger, et al.. (2013). Patient‐Reported Outcomes and the Association With Clinical Response in Patients With Active Psoriatic Arthritis Treated With Golimumab: Findings Through 2 Years of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial. Arthritis Care & Research. 65(10). 1666–1673. 45 indexed citations

19.

Tandon, Neeta, Rebecca Bolce, S. Bolge, et al.. (2012). PMS66 Satisfaction with and Preference for Golimumab and its Auto-Injector among Rheumatoid Arthritis Patients Switched from Adalimumab or Etanercept. Value in Health. 15(4). A45–A46. 5 indexed citations

20.

Kavanaugh, Arthur, Iain B. McInnes, Gerald G. Krueger, et al.. (2011). PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL. Value in Health. 14(3). A135–A135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact